Skip to main content
Erschienen in: Journal of Neural Transmission 9/2009

01.09.2009 | Basic Neurosciences, Genetics and Immunology - Short Communication

Naloxone decreases the inhibitory effect of ethanol on the release of arginine-vasopressin induced by physical exercise in man

verfasst von: Vittorio Coiro, A. Casti, E. Volta, A. Melani, M. L. Maffei, P. Rubino, P. Vacca, G. Saccani-Jotti, R. Volpi, P. Chiodera

Erschienen in: Journal of Neural Transmission | Ausgabe 9/2009

Einloggen, um Zugang zu erhalten

Abstract

To establish whether ethanol and/or endogenous opioids play a role in the control of arginine-vasopressin (AVP) response to physical exercise, six healthy men underwent six bicycle-ergometer tests until exhaustion [exercise control test; exercise plus ethanol (50 of 110 ml proof whiskey orally), exercise plus naloxone (2 mg injected plus 5 mg infused or 4 mg injected plus 10 mg infused intravenously] or exercise plus ethanol plus naloxone). Plasma AVP levels, physiological and biochemical variables were measured during tests. Physiological and biochemical variables were similar in all tests. During the control test, exercise significantly increased plasma AVP levels, with a peak value five times higher than baseline. The AVP response to exercise was similar in the presence of naloxone, whereas it was abolished by ethanol. When ethanol tests were repeated in the presence of naloxone, at both lower and higher dose, ethanol inhibition on AVP secretion was only partial, with mean peak responses 2.5 times higher than basal values. Results indicate an ethanol involvement in regulation of the AVP response to physical exercise. Furthermore, naloxone-sensitive endogenous opioids appear to play a role in the mechanism underlying ethanol inhibitory action, but not in mediation of the AVP response to physical exercise.
Literatur
Zurück zum Zitat Chiodera P, Coiro V (1990) Inhibitory effect of ethanol on the arginine-vasopressin response to insulin-induced hypoglycaemia and the role of endogenous opioids. Neuroendocrinology 51:501–504PubMedCrossRef Chiodera P, Coiro V (1990) Inhibitory effect of ethanol on the arginine-vasopressin response to insulin-induced hypoglycaemia and the role of endogenous opioids. Neuroendocrinology 51:501–504PubMedCrossRef
Zurück zum Zitat Chiodera P, d’Amato L, Davoli C, Delsignore R, Gnudi A, Coiro V (1987) Naloxone decreases the inhibitory effect of ethanol on the release of arginine-vasopressin mediated by cigarette smoking in man. Metabolism 36:804–806PubMedCrossRef Chiodera P, d’Amato L, Davoli C, Delsignore R, Gnudi A, Coiro V (1987) Naloxone decreases the inhibitory effect of ethanol on the release of arginine-vasopressin mediated by cigarette smoking in man. Metabolism 36:804–806PubMedCrossRef
Zurück zum Zitat Chiodera P, Gnudi A, Volpi R, d’Amato L, Marchesi C, Pioli G, Muzzetto P, Castelli A, Bianconi L, Minelli R, Gelmini G, Coiro V (1988) Metergoline, naloxone and sodium valproate did not modify arginine-vasopressin response to insulin-induced hypoglycaemia in man. J Endocrinol Invest 11:365–369PubMed Chiodera P, Gnudi A, Volpi R, d’Amato L, Marchesi C, Pioli G, Muzzetto P, Castelli A, Bianconi L, Minelli R, Gelmini G, Coiro V (1988) Metergoline, naloxone and sodium valproate did not modify arginine-vasopressin response to insulin-induced hypoglycaemia in man. J Endocrinol Invest 11:365–369PubMed
Zurück zum Zitat Coiro V, Chiodera P (1991) Naloxone increases the Angiotensin II-stimulated rise of arginine vasopressin and oxytocin secretion in man. Neuroendocrinology 53:209–213PubMedCrossRef Coiro V, Chiodera P (1991) Naloxone increases the Angiotensin II-stimulated rise of arginine vasopressin and oxytocin secretion in man. Neuroendocrinology 53:209–213PubMedCrossRef
Zurück zum Zitat Convertino VA, Keil LC, Bernauer EM, Greenleaf JE (1981) Plasma volume, osmolality, vasopressin and renin activity during graded exercise in man. J Appl Physiol 50:123–128PubMed Convertino VA, Keil LC, Bernauer EM, Greenleaf JE (1981) Plasma volume, osmolality, vasopressin and renin activity during graded exercise in man. J Appl Physiol 50:123–128PubMed
Zurück zum Zitat Cox BM (1982) Endogenous opioid peptides: a guide to structures and terminology. Life Sci 13:1645–1658CrossRef Cox BM (1982) Endogenous opioid peptides: a guide to structures and terminology. Life Sci 13:1645–1658CrossRef
Zurück zum Zitat Husain MK, Frantz AG, Ciarochi F, Robinson AG (1975) Nicotine-stimulated release of neurophysin and vasopressin in humans. J Clin Endocrinol Metab 41:1113–1117PubMedCrossRef Husain MK, Frantz AG, Ciarochi F, Robinson AG (1975) Nicotine-stimulated release of neurophysin and vasopressin in humans. J Clin Endocrinol Metab 41:1113–1117PubMedCrossRef
Zurück zum Zitat Lightman SL, Forsling ML (1980) Evidence for endogenous opioid control of vasopressin release in man. J Clin Endocrinol Metab 50:251–257CrossRef Lightman SL, Forsling ML (1980) Evidence for endogenous opioid control of vasopressin release in man. J Clin Endocrinol Metab 50:251–257CrossRef
Zurück zum Zitat Lightman SL, Langdon N, Forsling ML (1980) Effects of opiate antagonist naloxone and the enkephalin analog DAMME on the vasopressin response to a hypertonic stimulus in man. J Clin Endocrinol Metab 51:1447–1449PubMedCrossRef Lightman SL, Langdon N, Forsling ML (1980) Effects of opiate antagonist naloxone and the enkephalin analog DAMME on the vasopressin response to a hypertonic stimulus in man. J Clin Endocrinol Metab 51:1447–1449PubMedCrossRef
Zurück zum Zitat Lightman SL, Langdon N, Todd K, Forsling ML (1982) Naloxone increases the nicotine-stimulated rise of vasopressin secretion in man. Clin Endocrinol 16:353–358CrossRef Lightman SL, Langdon N, Todd K, Forsling ML (1982) Naloxone increases the nicotine-stimulated rise of vasopressin secretion in man. Clin Endocrinol 16:353–358CrossRef
Zurück zum Zitat Melin B, Echlache JP, Geelen G, Annat G, Alleward AM, Jarvaillon E, Zebidi A, Legros JJ, Gharie CL (1989) Plasma AVP, neurophysin, rennin activity and aldosterone during submaximal exercise performance until exhaustion in trained and untrained men. Eur J Appl Physiol 44:141–145CrossRef Melin B, Echlache JP, Geelen G, Annat G, Alleward AM, Jarvaillon E, Zebidi A, Legros JJ, Gharie CL (1989) Plasma AVP, neurophysin, rennin activity and aldosterone during submaximal exercise performance until exhaustion in trained and untrained men. Eur J Appl Physiol 44:141–145CrossRef
Zurück zum Zitat Morley JE (1983) Neuroendocrine effects of endogenous opioid peptides in human subjects: a review. Psychoneuroendocrinology 8:361–379PubMedCrossRef Morley JE (1983) Neuroendocrine effects of endogenous opioid peptides in human subjects: a review. Psychoneuroendocrinology 8:361–379PubMedCrossRef
Zurück zum Zitat Oiso Y, Robertson GL (1985) Effect of ethanol on vasopressin secretion and the role of endogenous opioids. In: Schrier RW (ed) Vasopressin, Raven Press, New York, pp 265–269 Oiso Y, Robertson GL (1985) Effect of ethanol on vasopressin secretion and the role of endogenous opioids. In: Schrier RW (ed) Vasopressin, Raven Press, New York, pp 265–269
Zurück zum Zitat Wade CE, Claybaugh JR (1980) Plasma rennin, activity, vasopressin concentration and urinary excretory response to exercise in man. J Appl Physiol 49:930–936PubMed Wade CE, Claybaugh JR (1980) Plasma rennin, activity, vasopressin concentration and urinary excretory response to exercise in man. J Appl Physiol 49:930–936PubMed
Zurück zum Zitat Wittertt GA, Steward DE, Graves M, Ellis M, Evans MJ, Wells JE, Donald RA, Espiner EA (1991) Plasma corticotrophin releasing factor and vasopressin responses to exercise in normal man. Clin Endocrinol 35:311–317CrossRef Wittertt GA, Steward DE, Graves M, Ellis M, Evans MJ, Wells JE, Donald RA, Espiner EA (1991) Plasma corticotrophin releasing factor and vasopressin responses to exercise in normal man. Clin Endocrinol 35:311–317CrossRef
Metadaten
Titel
Naloxone decreases the inhibitory effect of ethanol on the release of arginine-vasopressin induced by physical exercise in man
verfasst von
Vittorio Coiro
A. Casti
E. Volta
A. Melani
M. L. Maffei
P. Rubino
P. Vacca
G. Saccani-Jotti
R. Volpi
P. Chiodera
Publikationsdatum
01.09.2009
Verlag
Springer Vienna
Erschienen in
Journal of Neural Transmission / Ausgabe 9/2009
Print ISSN: 0300-9564
Elektronische ISSN: 1435-1463
DOI
https://doi.org/10.1007/s00702-009-0270-5

Weitere Artikel der Ausgabe 9/2009

Journal of Neural Transmission 9/2009 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.